201 related articles for article (PubMed ID: 32416978)
1. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
Witz CA; Daftary GS; Doody KJ; Park JK; Seifu Y; Yankov VI; Heiser PW;
Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
[TBL] [Abstract][Full Text] [Related]
2. The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin.
Arce JC; Klein BM; La Marca A
Gynecol Endocrinol; 2014 Jun; 30(6):444-50. PubMed ID: 24576226
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
4. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.
Devroey P; Pellicer A; Nyboe Andersen A; Arce JC;
Fertil Steril; 2012 Mar; 97(3):561-71. PubMed ID: 22244781
[TBL] [Abstract][Full Text] [Related]
5. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
6. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial.
Robins JC; Khair AF; Widra EA; Alper MM; Nelson WW; Foster ED; Sinha A; Ando M; Heiser PW; Daftary GS
F S Rep; 2020 Dec; 1(3):257-263. PubMed ID: 34223253
[TBL] [Abstract][Full Text] [Related]
8. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
Ishihara O; Klein BM; Arce JC;
Fertil Steril; 2021 Jun; 115(6):1478-1486. PubMed ID: 33272623
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
[TBL] [Abstract][Full Text] [Related]
10. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
11. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
12. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
Schwarze JE; Crosby JA; Zegers-Hochschild F
Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
[TBL] [Abstract][Full Text] [Related]
13. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
14. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
15. Human Menopausal Gonadotropin Commenced on Early Follicular Period Increases Live Birth Rates in POSEIDON Group 3 and 4 Poor Responders.
Berker B; Şükür YE; Özdemir EÜ; Özmen B; Sönmezer M; Atabekoğlu CS; Aytaç R
Reprod Sci; 2021 Feb; 28(2):488-494. PubMed ID: 32833190
[TBL] [Abstract][Full Text] [Related]
16. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
[TBL] [Abstract][Full Text] [Related]
17. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
19. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
Ye H; Huang G; Pei L; Zeng P; Luo X
Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
Boostanfar R; Gates D; Guan Y; Gordon K; McCrary Sisk C; Stegmann BJ
Fertil Steril; 2016 Aug; 106(2):300-305.e5. PubMed ID: 27090863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
